Searching Biomarkers of Acute Intestinal Ischemic Injuries
Recruiting
N/A
Interventional Study
Acute Mesenteric Ischemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 556 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the SURVIBIO study is to characterize accurate biomarkers for acute mesenteric ischemia, in particular at early stages.
In the study, the development of biomarkers will be based on the analysis of human biological samples from patients and controls that will be conserved in a biological library. Samples will be analysed in the Laboratory for Vascular Translational Sciences (LVTS, Inser…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age\> 18 years
* Acute abdominal pain requiring an injected abdominal injected CT scan, at best at non-injected / early arterial / portal time
* Admitted or attended in Beaujon and / or Bichat hospitals
* Patient covered by a social security scheme
* Written consent
Exclusion…
Contacts